New Additions to Drugs.com for 2012
The following 62 drugs were added to the Drugs.com database in 2012.
Eliquis
Dec 28, 2012 - Eliquis (apixaban) is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Juxtapid
Dec 26, 2012 - Juxtapid (lomitapide) is a microsomal triglyceride transfer protein inhibitor indicated for the treatment of patients with homozygous familial hypercholesterolemia.
Adasuve
Dec 26, 2012 - Adasuve (loxapine) is a typical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
Raxibacumab
Dec 26, 2012 - Raxibacumab is a human monoclonal antibody drug for the treatment of inhalational anthrax.
Raxibacumab
Dec 26, 2012 - Raxibacumab is a human monoclonal antibody drug for the treatment of inhalational anthrax.
Gattex
Dec 26, 2012 - Gattex (teduglutide) is a recombinant analog of human glucagon-like peptide 2 for the treatment of short bowel syndrome.
Signifor
Dec 19, 2012 - Signifor (pasireotide) is a multireceptor targeting somatostatin analog for the treatment of patients with Cushing's disease.
Iclusig
Dec 17, 2012 - Iclusig (ponatinib) is a kinase inhibitor for the treatment of chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Cometriq
Nov 29, 2012 - Cometriq (cabozantinib) is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer.
Flucelvax Quadrivalent
Nov 26, 2012 - Flucelvax Quadrivalent (influenza virus vaccine) is an inactivated vaccine indicated for the prevention of influenza.
Xeljanz
Nov 6, 2012 -
Synribo
Oct 28, 2012 - Synribo (omacetaxine mepesuccinate) is a first-in-class small molecule drug for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia.
Jetrea
Oct 24, 2012 - Jetrea (ocriplasmin) is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion.
Fycompa
Oct 23, 2012 - Fycompa (perampanel) is a non-competitive AMPA glutamate receptor antagonist indicated for the treatment of partial-onset seizures, and as adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy.
Cystaran
Oct 22, 2012 - Cystaran (cysteamine cysteamine ophthalmic solution) is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
Quillivant XR
Oct 1, 2012 - Quillivant XR (methylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Stivarga
Sep 27, 2012 - Stivarga (regorafenib) is an oral multi-kinase inhibitor for the treatment of
patients with metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma.
Aubagio
Sep 13, 2012 - Aubagio (teriflunomide) is an oral pyrimidine synthesis inhibitor indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Bosulif
Sep 4, 2012 -
Tbo-filgrastim
Sep 1, 2012 - Tbo-filgrastim is a leukocyte growth factor indicated for the reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs.
Xtandi
Aug 31, 2012 - Xtandi (enzalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
Linzess
Aug 31, 2012 -
Stribild
Aug 27, 2012 - Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.
Auvi-Q
Aug 15, 2012 - Auvi-Q (epinephrine injection) is a voice-guided epinephrine auto-injector for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.
Marqibo
Aug 14, 2012 - Marqibo (vincristine liposome injection) is a vinca alkaloid indicated for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL).
Zaltrap
Aug 8, 2012 - Zaltrap (ziv-aflibercept) is an angiogenesis inhibitor for the combination treatment of patients with metastatic colorectal cancer.
Rayos
Jul 30, 2012 - Rayos (prednisone) is a delayed release corticosteroid indicated as an anti-inflammatory or immunosuppressive agent to treat a broad
range of diseases including rheumatoid arthritis, polymyalgia
rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma and chronic obstructive pulmonary disease (COPD).
Vascepa
Jul 27, 2012 - Vascepa (icosapent ethyl) is a prescription medicine used together with a low-fat and low-cholesterol diet to reduce triglycerides in adults with severely high triglycerides, and to reduce the risk of cardiovascular events in adults with heart disease.
Tudorza Pressair
Jul 24, 2012 - Tudorza Pressair (aclidinium bromide inhalation powder) is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Kyprolis
Jul 24, 2012 - Kyprolis (carfilzomib) is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma.
Prepopik
Jul 18, 2012 - Prepopik (sodium picosulfate, magnesium oxide and citric acid) is a stimulant laxative and osmotic laxative combination indicated for cleansing of the colon as a preparation for colonoscopy in adults.
Qsymia
Jul 17, 2012 - Qsymia (phentermine and topiramate extended-release) is used together with diet and exercise to treat obesity.
Myrbetriq
Jun 29, 2012 - Myrbetriq (mirabegron) is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) and neurogenic detrusor overactivity.
Belviq
Jun 27, 2012 - Belviq (lorcaserin) is a serotonin 2C receptor agonist indicated for chronic weight management in adults who are obese or overweight, and who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
MenHibrix
Jun 20, 2012 - MenHibrix (Hib-MenCY-TT) is a combination vaccine for the active immunization of infants and young children 6 weeks through 18 months of age for the prevention of invasive diseases caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b (Hib).
Perjeta
Jun 8, 2012 - Perjeta (pertuzumab) is a humanized monoclonal antibody indicated in combination with Herceptin (trastuzumab) and docetaxel chemotherapy for the treatment of HER2-positive metastatic breast cancer.
Pertzye
May 20, 2012 - Pertzye (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Fabior
May 14, 2012 - Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.
Elelyso
May 6, 2012 - Elelyso (taliglucerase alfa) is a plant-cell expressed recombinant form of glucocerebrosidase for the treatment of Gaucher disease.
Dymista
May 2, 2012 - Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of symptoms of seasonal allergic rhinitis.
Stendra
Apr 27, 2012 - Stendra (avanafil) is a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED).
Amyvid
Apr 22, 2012 - Amyvid (florbetapir F 18) is a radioactive diagnostic agent used for brain imaging of beta-amyloid plaques in patients who are being evaluated for Alzheimer's Disease and other causes of cognitive decline.
Binosto
Mar 31, 2012 - Binosto (alendronate) is a buffered effervescent dosage form of the bisphosphonate drug alendronate sodium administered once weekly for the treatment of osteoporosis.
QNASL
Mar 29, 2012 - QNASL (beclomethasone dipropionate) is an intranasal corticosteroid non-aqueous "dry" spray formulation for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
Omontys
Mar 27, 2012 - Omontys (peginesatide) an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Surfaxin
Mar 7, 2012 - Surfaxin (lucinactant) is a synthetic, peptide-containing surfactant indicated for the prevention of respiratory distress syndrome (RDS) in premature infants.
Viokace
Mar 4, 2012 - Viokace (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases. Viokace, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.
Ultresa
Mar 4, 2012 - Ultresa (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Bio-T-Gel
Feb 22, 2012 - Bio-T-Gel (testosterone) is a once-daily transdermal testosterone gel for the treatment of male hypogonadism or low
testosterone levels.
Korlym
Feb 22, 2012 - Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance.
Zioptan
Feb 13, 2012 - Zioptan (tafluprost ophthalmic solution) is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Mitosol
Feb 9, 2012 - Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Feb 7, 2012 - Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and older.
Jentadueto
Feb 1, 2012 - Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Kalydeco
Jan 31, 2012 - Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients ages 4 months and older with a certain gene mutation.
Voraxaze
Jan 30, 2012 - Voraxaze (glucarpidase) is a carboxypeptidase enzyme indicated for the treatment of toxic plasma methotrexate levels in patients with delayed methotrexate clearance due to impaired renal function.
Erivedge
Jan 30, 2012 - Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell carcinoma (BCC).
Bydureon
Jan 27, 2012 - Bydureon (exenatide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Inlyta
Jan 27, 2012 - Inlyta (axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma.
Picato
Jan 26, 2012 - Picato (ingenol mebutate) is an inducer of cell death indicated for the topical treatment of actinic keratosis.
Zetonna
Jan 26, 2012 - Zetonna (ciclesonide) is corticosteroid nasal spray indicated for the treatment of symptoms associated with seasonal and perennial allergic rhinitis.
Subsys
Jan 8, 2012 - Subsys (fentanyl) is an opioid analgesic sublingual spray formulation indicated for the treatment of breakthrough cancer pain.